More SEC Filings
View Older Stories View Newer Stories-
Form SCHEDULE 13G/A Amneal Pharmaceuticals, Filed by: UBS Group AG
-
Form 13F-NT J. Safra Sarasin Asset For: Dec 31
-
Form 4 LABCORP HOLDINGS INC. For: Feb 06 Filed by: Wengel Kathryn E
-
Form 13F-HR CORNERSTONE ENTERPRISES, For: Dec 31
-
Form 4 LABCORP HOLDINGS INC. For: Feb 06 Filed by: Parham Richelle P
-
Form D 9821 Kansas City, DST
-
Form 4 LABCORP HOLDINGS INC. For: Feb 06 Filed by: NEUPERT PETER M
-
Form 13F-HR LFA - Lugano Financial For: Dec 31
-
Form 13F-NT J. Safra Sarasin Fund For: Dec 31
-
Form 6-K ASE Technology Holding For: Feb 10
-
Form 4 LABCORP HOLDINGS INC. For: Feb 06 Filed by: Kong Garheng
-
Form 6-K ONCOLYTICS BIOTECH INC For: Feb 07
-
Form 8-K HERTZ CORP For: Feb 10 Filed by: HERTZ GLOBAL HOLDINGS, INC
-
Form 4 TFS Financial CORP For: Feb 07 Filed by: Stefanski Gavin B
-
Form 8-K SEMPRA For: Feb 08
-
Form 13F-NT J. Safra Sarasin Investm For: Dec 31
-
Form 13F-HR Fore Capital, LLC For: Dec 31
-
Form 13F-HR Skandinaviska Enskilda For: Dec 31
-
Form 4 LABCORP HOLDINGS INC. For: Feb 06 Filed by: Davis Jeffrey A.
-
Form DEFA14A Rigel Resource Acquisiti
-
Form 13F-HR MAGNOLIA GROUP, LLC For: Dec 31
-
Form 8-K Rigel Resource Acquisiti For: Feb 10
-
Form 485APOS NEW YORK LIFE INVESTMENT
-
Form 4 LABCORP HOLDINGS INC. For: Feb 06 Filed by: Kliphouse Kirsten Marie
-
Form 10-Q Luvu Brands, Inc. For: Dec 31
-
Form 13F-NT Bank J. Safra Sarasin For: Dec 31
-
Form 424B2 UNION PACIFIC CORP
-
Form 8-K GOLD ROCK HOLDINGS, INC. For: Feb 06
-
Form 4 LABCORP HOLDINGS INC. For: Feb 06 Filed by: ANDERSON KERRII B
-
Form 8-K CSP INC /MA/ For: Feb 10
-
Form 8-K Fox Corp For: Feb 07
-
Form SCHEDULE 13G/A KIORA PHARMACEUTICALS Filed by: HIRSCHMAN ORIN
-
Form 4 3M CO For: Feb 07 Filed by: Rhodes Kevin H
-
Form 13F-NT TOUNJIAN ADVISORY PARTNE For: Dec 31
-
Form 4 LABCORP HOLDINGS INC. For: Feb 06 Filed by: Rothman Paul
-
Form 485BXT Investment Managers Seri
-
Form 8-K Okta, Inc. For: Feb 10
-
Form 8-K 4D Molecular Therapeutic For: Feb 08
-
Form 13F-NT BP INVESTMENT MANAGEMENT For: Dec 31
-
Form 485BXT Investment Managers Seri
-
Form 10-D First National Master For: Jan 31
-
Form SCHEDULE 13G/A Aprea Therapeutics, Inc. Filed by: HIRSCHMAN ORIN
-
Form 4 Structure Therapeutics For: Feb 06 Filed by: FMR LLC
-
Form 13F-NT Banque J. Safra Sarasin For: Dec 31
-
Form 4 LABCORP HOLDINGS INC. For: Feb 06 Filed by: Gilliland Dwight Gary
-
Form 424B2 CITIGROUP INC
-
Form 8-K Zeo ScientifiX, Inc. For: Feb 04
-
Form SCHEDULE 13G/A Coya Therapeutics, Inc. Filed by: HIRSCHMAN ORIN
-
Form 6-K Metalpha Technology Hold For: Feb 10
-
Form 13F-HR Erste Asset Management For: Dec 31

